Skip to content

Evaluating Two Multifocal Daily Disposable Contact Lenses

Evaluating the Success of Refitting Lens Wearers With MyDay Multifocal, Who Are Already Adapted to Clariti 1Day Multifocal 2-Add Design

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05579886
Enrollment
60
Registered
2022-10-14
Start date
2022-10-10
Completion date
2023-02-07
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbyopia

Brief summary

The objective of the study was to adapt existing multifocal soft lens wearers to a Control Lens for at least 2 weeks and then evaluate the success of switching them to the Test Lens, with a review after 2 weeks.

Detailed description

This prospective, bilateral eye, open label, non-randomized study compared the performance of 2 different designs of daily disposable multifocal contact lenses.

Interventions

Daily disposable multifocal soft lens with 2 add design (2ADD) for 2 weeks

DEVICETest Lens

Daily disposable multifocal soft lens with 3 add design (3ADD) for 2 weeks

Sponsors

Centre for Ocular Research & Education, Canada
CollaboratorOTHER
CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
42 Years to No maximum
Healthy volunteers
No

Inclusion criteria

A person was eligible for inclusion in the study if he/she: 1. Was at least 42 years of age and had full legal capacity to volunteer; 2. Had read and signed an information consent letter; 3. Self-reported having had a full eye examination in the previous two years; 4. Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week; 5. Was willing and able to follow instructions and maintain the appointment schedule; 6. Habitually wore multifocal soft contact lenses, for the past 3 months minimum (NOTE: the habitual contact lens type was restricted such that no more than one third were to be the clariti 1 day multifocal and no more than one third were to be MyDay multifocal (this included their equivalent private label brand name); 7. Had refractive astigmatism no higher than -0.75DC in each eye; 8. Was presbyopic and required a reading addition of at least +0.75D and no more than +2.50D in each eye; 9. Could be fit and achieved binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deemed to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS)

Exclusion criteria

A person was excluded from the study if he/she: 1. Was participating in any concurrent clinical or research study; 2. Had any known active ocular disease and/or infection that contraindicated contact lens wear; 3. Had a systemic condition that in the opinion of the investigator may have affected a study outcome variable; 4. Was using any systemic or topical medications that in the opinion of the investigator may have affected contact lens wear or a study outcome variable; 5. Had known sensitivity to the diagnostic sodium fluorescein to be used in the study; 6. Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment; 7. Had undergone refractive error surgery or interocular surgery.

Design outcomes

Primary

MeasureTime frameDescription
Comfort Just After Lens Insertion2 weeksSubjective rating measured on a scale of 0-10, 0.5 steps, where 0=Painful, 10=Can't feel the lenses.

Countries

United States

Participant flow

Participants by arm

ArmCount
All Study Participants
Includes all study participants
60
Total60

Baseline characteristics

CharacteristicAll Study Participants
Age, Continuous52.9 years
STANDARD_DEVIATION 6.9
Race and Ethnicity Not Collected— Participants
Sex: Female, Male
Female
50 Participants
Sex: Female, Male
Male
10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 600 / 60
other
Total, other adverse events
1 / 600 / 60
serious
Total, serious adverse events
0 / 600 / 60

Outcome results

Primary

Comfort Just After Lens Insertion

Subjective rating measured on a scale of 0-10, 0.5 steps, where 0=Painful, 10=Can't feel the lenses.

Time frame: 2 weeks

Population: All participants wore Control Lens and Test Lens in sequential order.

ArmMeasureValue (MEAN)Dispersion
Control Lens (2ADD)Comfort Just After Lens Insertion9.1 score on a scaleStandard Deviation 1.4
Test Lens (3ADD)Comfort Just After Lens Insertion9.2 score on a scaleStandard Deviation 1.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026